Real world study on adjuvant treatment of non-small cell lung cancer with commonly used anti-cancer traditional Chinese medicine injectio
Not Applicable
Recruiting
- Conditions
- SCLC
- Registration Number
- ITMCTR2100005212
- Lead Sponsor
- Beijing Hospital of Traditional Chinese Medicined
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Patients with primary lung cancer hospitalized in the oncology department of Beijing Traditional Chinese medicine hospital from January 1, 2016 to December 31, 2018 according to the standardized diagnosis and treatment guidelines;
(2) The patients were treated with platinum containing double drug chemotherapy for more than 2 cycles;
(3) Traditional Chinese medicine injection and Kang'ai injection were used simultaneously in chemotherapy.
Exclusion Criteria
At the same time, there are other primary malignant tumors; Lung tumor metastases from other sites to the lung; Pathological diagnosis was small cell lung cancer.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor markers;
- Secondary Outcome Measures
Name Time Method Overall survival;TCM Syndrome;KPS;